270 related articles for article (PubMed ID: 28348359)
1. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
4. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
5. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC).
Duconseil P; Adham M; Sauvanet A; Autret A; Périnel J; Chiche L; Mabrut JY; Tuech JJ; Mariette C; Turrini O
Ann Surg Oncol; 2018 Apr; 25(4):1017-1025. PubMed ID: 29392508
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
7. Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas.
Pagliari D; Saviano A; Serricchio ML; Dal Lago AA; Brizi MG; Lanza F; Manfredi R; Gasbarrini A; Attili F
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2858-2874. PubMed ID: 28682431
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
9. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
[TBL] [Abstract][Full Text] [Related]
11. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
12. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
13. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.
Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ
Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913
[TBL] [Abstract][Full Text] [Related]
14. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology.
Pais SA; Attasaranya S; Leblanc JK; Sherman S; Schmidt CM; DeWitt J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):489-95. PubMed ID: 17350894
[TBL] [Abstract][Full Text] [Related]
15. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
[TBL] [Abstract][Full Text] [Related]
16. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
17. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
18. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
19. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
[TBL] [Abstract][Full Text] [Related]
20. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]